Norbitec
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Pinnauallee 4, Uetersen, Schleswig-Holst...Phone Number
+49 4941227120Website
www.norbitec.deRevenue
$5.6 MillionIndustry
About Norbitec
Is Norbitec your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Norbitec, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Norbitec recently announced quarterly report
Click to see if Norbitec had a recent Job posting/layoffs
Product Launch: Get notified when Norbitec launches new products
Funding: Get notified immidiatlly once Norbitec has new funding data
Congratulate Masked Content for being promoted to Masked Content at Norbitec
Check out if Norbitec is spiking on competitors!
Check if Norbitec has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Norbitec
Find 2 more new buyers
Company Profile Activity
Activity Insights
Norbitec is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Norbitec is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Norbitec.
Norbitec Tech Stack
A closer look at the technologies used by Norbitec
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Norbitec
Norbitec GmbH, established in 2003 as a joint venture, specializes in the production of Erythropoietin (Epoetin zeta), a biotechnologically produced active ingredient used for treating anemia. The company has received central European approval for its products Silapo and Retacrit from the European Commission in December 2007, and in April 2023, it... Read More